Zurueck zur Suche

Reporte zur Charge EN2600

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 CO 1 FL 1 SC 1 MN 1

VAERS 2088000

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

moderat
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Fatigue Feeling abnormal Pain in extremity Piloerection Pyrexia Tremor Vibratory sense increased

Symptomtext

Super weak. Strange vibration running through my body, a fight or flight syndrome causing me to shake. Extreme tiredness, fevers that came and left through out the week - 50episodes, Goose bumps, chills, mental fog, and sore arm. All of these symptoms lasted one week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
Scleroderma
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1106819

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

moderat
Staat
-
Alter
-
Geschlecht
U
Eingang
16.03.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Body temperature increased Dyspnoea

Symptomtext

Pt reported difficulty breathing 20 minutes after second dose of pfizer vaccine for covid. Pt was self premedicated with beandryl because she had history of allergic reaction to turkey during thanksgiving which lead to hospitalization. Pt requested for epipen and two doses were given while we were waiting for paramedics. Per the paramedics, pt had full air capacity with lungs completely full oxygen saturation was 98 percent, body temperaure was 99.4. and heart rate 142.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Oxygen saturation 98 percent, heart rate 142,, body temp 99.4
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1041651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

mild
Staat
CO
Alter
66,0
Geschlecht
F
Eingang
19.02.2021
Impfdatum
17.02.2021
Beginn
17.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site swelling

Symptomtext

Patient received her first dose of Pfizer COVID. Lot # EN2600 Site: RD Patient started to develop swelling to her right shoulder at the injection site where she had a COVID-19 vaccinate. Patient was referred by the vaccinator staff to go to the ER for evaluation. During the examination, patient denied any itching, redness, or new rash. Patient also denied any sensation of tongue, throat, or neck swelling. Patient also denied SOB or palpitation during visit. She denied history of allergy to eggs. For the swelling at the injection area, she said it was mildly sore but not particularly painful.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No Known Allergy
Vorherige Impfungen
-

VAERS 2020836

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

gering
Staat
FL
Alter
69,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
08.03.2021
Beginn
05.01.2022
Tage bis Beginn
303,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

patient hospitalized

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1674285

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

gering
Staat
SC
Alter
69,0
Geschlecht
F
Eingang
04.09.2021
Impfdatum
16.02.2021
Beginn
17.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Lymphadenopathy

Symptomtext

Enlarged lymph glands under left arm; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN2600) via an unspecified route of administration in the left arm on 16Feb2021 at 15:00 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, hypothyroidism, cardiovascular disease and asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT HFA), levothyroxine (MANUFACTURER UNKNOWN), hydrochlorothiazide (THIAZIDE) and me (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) on an unknown date for unknown indication and experienced drug allergy and received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via an unspecified route of administration in the left arm on 26Jan2021 at 12:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Feb2021, the patient experienced enlarged lymph glands under left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for enlarged lymph glands under left arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph glands under left arm was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymphadenopathy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Breast cancer; Cardiovascular disorder (cardiovascular disease); Hypothyroidism
Andere Medikamente
FLOVENT HFA; LEVOTHYROXINE; HYDROCHLOROTHIAZIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1230027

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

gering
Staat
MN
Alter
51,0
Geschlecht
M
Eingang
19.04.2021
Impfdatum
17.02.2021
Beginn
15.04.2021
Tage bis Beginn
57,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asymptomatic COVID-19 Exposure to SARS-CoV-2 SARS-CoV-2 test positive

Symptomtext

Had positive COVID-19 by PCR result on 4/15/21, >2 weeks after 2nd COVID vaccination. Asymptomatic, known exposure to COVID positive person.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Asymptomatic COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1080216

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN2600

gering
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
18.02.2021
Beginn
20.02.2021
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site erythema

Symptomtext

Redness at injection site on day 2; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN2600) on left arm, via an unspecified route of administration on 18Feb2021 15:00 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient experienced redness at injection site on day 2 on 20Feb2021 13:30. There was no treatment received for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The event was reported as non-serious. The outcome of the event was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-